BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38639364)

  • 41. HbA1c and the risks for all-cause and cardiovascular mortality in the general Japanese population: NIPPON DATA90.
    Sakurai M; Saitoh S; Miura K; Nakagawa H; Ohnishi H; Akasaka H; Kadota A; Kita Y; Hayakawa T; Ohkubo T; Okayama A; Okamura T; Ueshima H;
    Diabetes Care; 2013 Nov; 36(11):3759-65. PubMed ID: 23877989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank.
    Welsh C; Welsh P; Celis-Morales CA; Mark PB; Mackay D; Ghouri N; Ho FK; Ferguson LD; Brown R; Lewsey J; Cleland JG; Gray SR; Lyall DM; Anderson JJ; Jhund PS; Pell JP; McGuire DK; Gill JMR; Sattar N
    Diabetes Care; 2020 Feb; 43(2):440-445. PubMed ID: 31852727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of hemoglobin A
    Lee A; Haddad D; Rybin D; Howell C; Ghaderi I; Berman S; Zhou W; Tan TW
    J Vasc Surg; 2021 Apr; 73(4):1332-1339.e5. PubMed ID: 32730894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study.
    Navarro-Pérez J; Orozco-Beltran D; Gil-Guillen V; Pallares V; Valls F; Fernandez A; Perez-Navarro AM; Sanchis C; Dominguez-Lucas A; Martin-Moreno JM; Redon J; Tellez-Plaza M;
    BMC Cardiovasc Disord; 2018 Sep; 18(1):180. PubMed ID: 30176799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study.
    Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL
    Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visit-to-Visit Variability of Hemoglobin A
    Ghouse J; Skov MW; Kanters JK; Lind B; Isaksen JL; Blanche P; Haunsø S; Køber L; Svendsen JH; Olesen MS; Holst AG; Gerds TA; Nielsen JB
    Diabetes Care; 2019 Jan; 42(1):134-141. PubMed ID: 30352898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study.
    Gao L; Matthews FE; Sargeant LA; Brayne C;
    BMC Public Health; 2008 Feb; 8():54. PubMed ID: 18267013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemoglobin a1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women.
    Pai JK; Cahill LE; Hu FB; Rexrode KM; Manson JE; Rimm EB
    J Am Heart Assoc; 2013 Mar; 2(2):e000077. PubMed ID: 23537807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe.
    Orchard TJ; Stevens LK; Forrest KY; Fuller JH
    Int J Epidemiol; 1998 Dec; 27(6):976-83. PubMed ID: 10024191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycated hemoglobin measurement and prediction of cardiovascular disease.
    ; Di Angelantonio E; Gao P; Khan H; Butterworth AS; Wormser D; Kaptoge S; Kondapally Seshasai SR; Thompson A; Sarwar N; Willeit P; Ridker PM; Barr EL; Khaw KT; Psaty BM; Brenner H; Balkau B; Dekker JM; Lawlor DA; Daimon M; Willeit J; Njølstad I; Nissinen A; Brunner EJ; Kuller LH; Price JF; Sundström J; Knuiman MW; Feskens EJ; Verschuren WM; Wald N; Bakker SJ; Whincup PH; Ford I; Goldbourt U; Gómez-de-la-Cámara A; Gallacher J; Simons LA; Rosengren A; Sutherland SE; Björkelund C; Blazer DG; Wassertheil-Smoller S; Onat A; Marín Ibañez A; Casiglia E; Jukema JW; Simpson LM; Giampaoli S; Nordestgaard BG; Selmer R; Wennberg P; Kauhanen J; Salonen JT; Dankner R; Barrett-Connor E; Kavousi M; Gudnason V; Evans D; Wallace RB; Cushman M; D'Agostino RB; Umans JG; Kiyohara Y; Nakagawa H; Sato S; Gillum RF; Folsom AR; van der Schouw YT; Moons KG; Griffin SJ; Sattar N; Wareham NJ; Selvin E; Thompson SG; Danesh J
    JAMA; 2014 Mar; 311(12):1225-33. PubMed ID: 24668104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycemic Markers and Subclinical Cardiovascular Disease: The Jackson Heart Study.
    Echouffo-Tcheugui JB; Chen H; Kalyani RR; Sims M; Simpson S; Effoe VS; Correa A; Bertoni AG; Golden SH
    Circ Cardiovasc Imaging; 2019 Mar; 12(3):e008641. PubMed ID: 30879330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative.
    Singh N; Zeng C; Lewinger JP; Wolfson AM; Shavelle D; Weaver F; Garg PK
    J Vasc Surg; 2019 Oct; 70(4):1225-1234.e1. PubMed ID: 30852042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes with poor-control HbA1c is cardiovascular disease 'risk equivalent' for mortality: UK Biobank and Hong Kong population-based cohort study.
    Wan EYF; Yu EYT; Mak IL; Youn HM; Chan KS; Chan EWY; Wong ICK; Lam CLK
    BMJ Open Diabetes Res Care; 2023 Jan; 11(1):. PubMed ID: 36634978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetes, Glycated Hemoglobin, and the Risk of Myocardial Infarction in Women and Men: A Prospective Cohort Study of the UK Biobank.
    de Jong M; Woodward M; Peters SAE
    Diabetes Care; 2020 Sep; 43(9):2050-2059. PubMed ID: 32651263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
    Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
    J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A
    Lu J; He J; Li M; Tang X; Hu R; Shi L; Su Q; Peng K; Xu M; Xu Y; Chen Y; Yu X; Yan L; Wang T; Zhao Z; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Du R; Cheng D; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Chen L; Zhao J; Mu Y; Ning G; Wang W; Bi Y;
    Diabetes Care; 2019 Aug; 42(8):1539-1548. PubMed ID: 31152120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Leite NC; Ferreira MT; Salles GF
    Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemoglobin A1c Level and Cardiovascular Disease Incidence in Persons With Type 1 Diabetes: An Application of Joint Modeling of Longitudinal and Time-to-Event Data in the Pittsburgh Epidemiology of Diabetes Complications Study.
    Miller RG; Anderson SJ; Costacou T; Sekikawa A; Orchard TJ
    Am J Epidemiol; 2018 Jul; 187(7):1520-1529. PubMed ID: 29394305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mean HbA
    Forbes A; Murrells T; Mulnier H; Sinclair AJ
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
    Wadén J; Forsblom C; Thorn LM; Gordin D; Saraheimo M; Groop PH;
    Diabetes; 2009 Nov; 58(11):2649-55. PubMed ID: 19651819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.